Croda plans strategic review of chemicals
Croda International is to conduct a strategic review of its Performance Technologies and Industrial Chemicals (PTIC) businesses during 2021, to decide on the best ownership structure going forward. Full or partial divestment and a spin-off are all options, the company said.
The review will focus on the businesses and activities within PTIC that do not directly support the consumer care and life sciences sectors. These now account for over 80% of Croda’s profits and are enjoying faster growth. The company is already prioritising investment in these areas. PTIC is focused on the circular plastic economy, electric vehicles and other renewable technologies.
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
SOCMA, the trade association of the US speciality chemical manufacturing industry, has published an open letter to the pending Trump administration, urging it to “prioritise policies that encourage advancement, streamline regulatory processes and incentivise domestic manufacturing”.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion project at its Shanghai manufacturing site. This is due to be complete in 2H 2025 and will produce over 8 tonnes/year of crude peptide.
